BeyondSpring Competitors and Similar CompaniesClear all
BeyondSpring's competitors and similar companies include Omeros.
 BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. |  Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. | |
Founding Date | Founding Date 2010 | Founding Date 1994 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Florham Park, US HQ | Locations Seattle, US HQ |
Employees | Employees 4014% increase | Employees 1968% decrease |
Valuation ($) | Valuation ($) 89.4 m | Valuation ($) 248.6 m |
Financial | ||
Net income | Net income ($16.7m) (FY, 2024) | Net income ($3.4m) (FY, 2025) |
Operating ⚠ | ||
Patents (US) | Patents (US) 20 (Mar, 2020) | Patents (US) 80 (FY, 2021) |
Phase I Trials Products | Phase I Trials Products 2 (FY, 2019) | Phase I Trials Products 3 (FY, 2021) |
Phase II Trials Products | Phase II Trials Products 1 (FY, 2017) | Phase II Trials Products 2 (FY, 2021) |
Phase III Trials Products | Phase III Trials Products 3 (FY, 2019) | Phase III Trials Products 2 (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 36.1m | Total funding raised $ 354.8m |
For sources of this data, please see the company profile
View Company Profiles
Omeros
HQ
Seattle, US
Employees
196↓ 8% decrease
Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers.
View company